Invitation to presentation of Xbrane Biopharma’s interim report January – March 2022 on May 5, 2022.

Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Thursday, May 5, 2022, at 11.00 a.m. CET. Xbrane will publish the company’s interim report January – March 2022, on Thursday, May 5, 2022, at 8.00 a.m. CET.

Martin Åmark, CEO, and Anette Lindqvist, CFO/IR, will present the interim report January – March 2022, followed by a Q&A session. The presentation will be in English. To attend, please follow the link or dial-in at one of the numbers below:

Web link:
Xbrane interim report January - March 2022 presentation

Confirmation Code: 304 98 28
Standard international: +44 (0) 2071 928 338
UK (Local): +44 (0) 844 481 97 52
UK (Tollfree): +44 (0) 800 279 66 19
Sweden (Local): +46 (0) 856 618 467
Sweden (TollFree): +46 (0) 200 125 160
US (Local): +1 646 741 31 67
US (TollFree): +1 877 870 91 35

Datum 2022-05-02, kl 14:00
Källa MFN
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.